April 12, 2022
Dirix L et al. Breast Cancer Research and Treatments, 2022
Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer
You might also be interested by
Press Releases
CellCarta Launches Digital Pathology and AI Consortium to Accelerate Platform-Agnostic Biomarker Innovation Across Drug Development
July 15, 2026
More infoCellTalk Blog
CAR Kinetics in Autoimmune Studies: Expert Insights on Designing Effective Monitoring Strategies
June 30, 2026
More info